Skip to main content
. 2019 Jul 25;11(8):1051. doi: 10.3390/cancers11081051

Figure 6.

Figure 6

Final model with five specific biomarkers predicting GVHD with cross validation shows strong performance accuracy to predict GVHD (A). The cross-validation for the SVM method for model building and performance evaluation is performed multiple times to test a model with five specific biomarkers and it shows that the model can predict GVHD patients without misclassification (B).